The U.S. State Department has announced that the President's Emergency Plan for AIDS Relief (PEPFAR) will continue to receive a waiver for life-saving humanitarian assistance during a 90-day pause in foreign aid. Pfizer has resolved a lawsuit by a conservative group that alleged discrimination in its diversity fellowship program. A New York doctor has been indicted for prescribing an abortion pill to a teenager in Louisiana. AstraZeneca has scrapped plans to invest in its vaccine manufacturing plant in northern England due to a cut in British government support. U.S. health agencies have removed webpages with HIV and other data to comply with Trump administration orders on gender identity and diversity. Shares of weight-loss drug developer Metsera surged in its Nasdaq debut, valuing the company at $2.68 billion. The U.S. government may seek over $1 billion from Johnson & Johnson as reimbursement for medical costs related to cancer treatment. Aid flow into the Gaza Strip is likely to ease the acute food emergency, but the long-term health problems linked to childhood malnutrition remain a threat. Another case of the mpox variant clade lb has been detected in England. Maze Therapeutics has made its debut on the Nasdaq, with a lukewarm market reaction.